Archives for March 2013

Quizartinib Significantly Increases Survival For AML Patients With FLT3 Mutations

The FLT3-ITD tandem duplication mutation is the most common mutation in AML and this mutation renders the FLT3 enzyme constitutively active, sending a constant growth signal to malignant myeloid cells. The presence of this mutation results in a… [Learn More…]